scispace - formally typeset
Search or ask a question
Institution

American Cancer Society

NonprofitAtlanta, Georgia, United States
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.


Papers
More filters
Posted ContentDOI
07 May 2020-medRxiv
TL;DR: Long-term exposure to NO2, which largely arises from urban combustion sources such as traffic, may enhance susceptibility to severe COVID-19 outcomes, independent of long-term PM2.5 and O3 exposure, and the results support targeted public health actions to protect residents from COIDs19 in heavily polluted regions with historically high NO2 levels.
Abstract: Background The novel human coronavirus disease 2019 (COVID-19) pandemic has claimed more than 240,000 lives worldwide, causing tremendous public health, social, and economic damages. While the risk factors of COVID-19 are still under investigation, environmental factors, such as urban air pollution, may play an important role in increasing population susceptibility to COVID-19 pathogenesis. Methods We conducted a cross-sectional nationwide study using zero-inflated negative binomial models to estimate the association between long-term (2010-2016) county-level exposures to NO2, PM2.5 and O3 and county-level COVID-19 case-fatality and mortality rates in the US. We used both single and multipollutant models and controlled for spatial trends and a comprehensive set of potential confounders, including state-level test positive rate, county-level healthcare capacity, phase-of-epidemic, population mobility, sociodemographic, socioeconomic status, behavior risk factors, and meteorological factors. Results 1,027,799 COVID-19 cases and 58,489 deaths were reported in 3,122 US counties from January 22, 2020 to April 29, 2020, with an overall observed case-fatality rate of 5.8%. Spatial variations were observed for both COVID-19 death outcomes and long-term ambient air pollutant levels. County-level average NO2 concentrations were positively associated with both COVID-19 case-fatality rate and mortality rate in single-, bi-, and tri-pollutant models (p-values 0.05), although per IQR increase in PM2.5 (3.4 ug/m3) was marginally associated with 10.8% (95% CI: −1.1% to 24.1%) increase in COVID-19 mortality rate. Discussions and Conclusions Long-term exposure to NO2, which largely arises from urban combustion sources such as traffic, may enhance susceptibility to severe COVID-19 outcomes, independent of longterm PM2.5 and O3 exposure. The results support targeted public health actions to protect residents from COVID-19 in heavily polluted regions with historically high NO2 levels. Moreover, continuation of current efforts to lower traffic emissions and ambient air pollution levels may be an important component of reducing population-level risk of COVID-19 deaths.

99 citations

Journal ArticleDOI
TL;DR: While use of observation is increasing in low-risk groups, the use of RP is increasing across all risk groups with a concomitant decline in use of radiotherapy.

99 citations

Journal Article
TL;DR: A modest role for plant foods in reducing the risk of fatal stomach cancer in men, but not in women is supported, as well as an unexpected increased risk with vegetable consumption in women.
Abstract: Frequent consumption of fruits, vegetables, and whole grains has been associated with a reduced risk of stomach cancer in the majority of case-control studies of these factors: however, prospective studies have been less consistent. We examined the association between selected major food groups (citrus fruits, vegetables, whole grains, and processed meats) and risk of fatal stomach cancer in the Cancer Prevention Study (CPS) II cohort of 1.2 million United States men and women. During 14 years of follow-up, we documented 439 stomach cancer deaths in women and 910 in men after exclusion of individuals with prevalent cancers, inadequate diet information, and recent weight loss at baseline in 1982. After controlling for other risk factors, none of the food groups examined were associated with risk of stomach cancer except for an unexpected increased risk with vegetable consumption in women [relative risk (RR) = 1.25; 95% confidence interval (CI), 0.99-1.58; highest versus lowest tertile, P = 0.06 for trend]. A high overall plant food intake (a sum of vegetables, citrus fruit, and whole grains) was associated with reduced risk in men (RR = 0.79; 95% CI, 0.67-0.93; highest versus lowest tertile, P = 0.003 for trend), but not in women (RR = 1.18; 95% CI, 0.93-1.50; P = 0.16 for trend). Of individual foods examined, liver consumption greater than twice/week was associated with an increased risk of fatal stomach cancer in women (RR = 1.96; 95% CI, 1.09-3.53) and men (RR = 1.63; 95% CI, 1.02-2.62) compared with nonconsumers. This study supports a modest role for plant foods in reducing the risk of fatal stomach cancer in men, but not in women.

99 citations

Journal ArticleDOI
15 Jun 1984-Cancer
TL;DR: Overall treatment time influenced pelvic control in all cases when the size of the lesion was ≧6 cm.
Abstract: This is a retrospective analysis of 264 patients with Stage IB and IIA-B carcinoma of the cervix treated with curative intent at the University of Florida from October 1964 through April 1980. There is a minimum 2-year follow-up. Patients dead of distant metastases (13), dead from intercurrent disease (14), or lost to follow-up (1) less than 24 months from treatment with pelvic disease controlled were excluded from analysis of pelvic control. All patients were included in analysis of complications and survival. Tumor size and hematocrit were noted to be significant prognostic factors with regard to control of disease in the pelvis in Stage IB and IIA cancers. Tumor size and hematocrit also influenced pelvic control in Stage IIB, but to a lesser extent than in Stages IB and IIA. Patient age was a weak prognostic factor for control of disease in the pelvis for Stages IB, IIA, and IIB, but more strongly influenced pelvic control when considered in conjunction with tumor size and hematocrit. Overall treatment time influenced pelvic control in all cases when the size of the lesion was greater than or equal to 6 cm. In lesions greater than or equal to 6 cm in diameter, the amount of tumor regression noted at the time of the radium application after 3500 to 4000 rad external beam irradiation was a predictor of pelvic control. Data on treatment complications and survival are included, and future treatment strategies discussed.

99 citations

Journal ArticleDOI
Ghislaine Scelo1, Mark P. Purdue2, Kevin M. Brown2, Mattias Johansson1, Zhaoming Wang3, Jeanette E. Eckel-Passow4, Yuanqing Ye5, Jonathan N. Hofmann2, Jiyeon Choi2, Matthieu Foll1, Valerie Gaborieau1, Mitchell J. Machiela2, Leandro M. Colli2, Peng Li1, Joshua N. Sampson2, Behnoush Abedi-Ardekani1, Céline Besse6, Hélène Blanché7, Anne Boland6, Laurie Burdette2, Amelie Chabrier1, Geoffroy Durand1, Florence Le Calvez-Kelm1, Egor Prokhortchouk8, Nivonirina Robinot1, Konstantin G. Skryabin8, Magdalena B. Wozniak1, Meredith Yeager2, Gordana Basta-Jovanovic9, Zoran Dzamic9, Lenka Foretova, Ivana Holcatova10, Vladimir Janout11, Dana Mates, Anush Mukeriya, Stefan Rascu12, David Zaridze, Vladimir Bencko13, Cezary Cybulski14, Eleonora Fabianova, Viorel Jinga12, Jolanta Lissowska, Jan Lubinski14, Marie Navratilova, Peter Rudnai, Neonila Szeszenia-Dabrowska, Simone Benhamou15, Geraldine Cancel-Tassin, Olivier Cussenot, Laura Baglietto16, Heiner Boeing, Kay-Tee Khaw17, Elisabete Weiderpass, Börje Ljungberg18, Raviprakash T. Sitaram18, Fiona Bruinsma19, Susan J. Jordan20, Susan J. Jordan21, Gianluca Severi, Ingrid Winship22, Ingrid Winship23, Kristian Hveem24, Lars J. Vatten24, Tony Fletcher25, Kvetoslava Koppova, Susanna C. Larsson26, Alicja Wolk26, Rosamonde E. Banks27, Peter Selby27, Douglas F. Easton17, Paul D.P. Pharoah17, Gabriella Andreotti2, Laura E. Beane Freeman2, Stella Koutros2, Demetrius Albanes2, Satu Männistö2, Stephanie J. Weinstein2, Peter E. Clark28, Todd L. Edwards28, Loren Lipworth28, Susan M. Gapstur29, Victoria L. Stevens29, Hallie Carol30, Matthew L. Freedman30, Mark Pomerantz30, Eunyoung Cho31, Peter Kraft30, Mark A. Preston32, Kathryn M. Wilson30, J. Michael Gaziano32, Howard D. Sesso30, Howard D. Sesso32, Amanda Black2, Neal D. Freedman2, Wen-Yi Huang2, John Anema33, Richard J. Kahnoski33, Brian R. Lane33, Brian R. Lane34, Sabrina L. Noyes35, David Petillo35, Bin Tean Teh35, Ulrike Peters36, Emily White36, Garnet L. Anderson36, Lisa Johnson36, Juhua Luo37, Julie E. Buring30, Julie E. Buring32, I-Min Lee32, I-Min Lee30, Wong-Ho Chow5, Lee E. Moore2, Christopher G. Wood5, Timothy Eisen38, Marc Henrion39, James Larkin, Poulami Barman4, Bradley C. Leibovich4, Toni K. Choueiri30, G. Mark Lathrop40, Nathaniel Rothman2, Jean-François Deleuze7, Jean-François Deleuze6, James D. McKay1, Alexander S. Parker4, Xifeng Wu5, Richard S. Houlston41, Paul Brennan1, Stephen J. Chanock2 
TL;DR: This paper conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four existing scans, totalling 10,784 cases and 20,406 controls of European ancestry.
Abstract: Previous genome-wide association studies (GWAS) have identified six risk loci for renal cell carcinoma (RCC). We conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four existing scans, totalling 10,784 cases and 20,406 controls of European ancestry. Twenty-four loci were tested in an additional 3,182 cases and 6,301 controls. We confirm the six known RCC risk loci and identify seven new loci at 1p32.3 (rs4381241, P=3.1 × 10-10), 3p22.1 (rs67311347, P=2.5 × 10-8), 3q26.2 (rs10936602, P=8.8 × 10-9), 8p21.3 (rs2241261, P=5.8 × 10-9), 10q24.33-q25.1 (rs11813268, P=3.9 × 10-8), 11q22.3 (rs74911261, P=2.1 × 10-10) and 14q24.2 (rs4903064, P=2.2 × 10-24). Expression quantitative trait analyses suggest plausible candidate genes at these regions that may contribute to RCC susceptibility.

99 citations


Authors

Showing all 1345 results

NameH-indexPapersCitations
Walter C. Willett3342399413322
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
David J. Hunter2131836207050
Edward Giovannucci2061671179875
Irving L. Weissman2011141172504
Bernard Rosner1901162147661
Susan E. Hankinson15178988297
Paolo Boffetta148145593876
Jeffrey A. Bluestone14351577080
Richard D. Smith140118079758
Garth D. Illingworth13750561793
Brian E. Henderson13771269921
Ahmedin Jemal132500380474
Michael J. Thun12939279051
Network Information
Related Institutions (5)
University of Texas MD Anderson Cancer Center
92.5K papers, 4.7M citations

89% related

Memorial Sloan Kettering Cancer Center
65.3K papers, 4.4M citations

89% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

88% related

Mayo Clinic
169.5K papers, 8.1M citations

86% related

University of California, San Francisco
186.2K papers, 12M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202312
20228
2021202
2020239
2019222
2018194